A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005439:Flufenamic Acid / Q000009:adverse effects / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood / Q000652:urine; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D062367:ortho-Aminobenzoates; D014527:Uric Acid; D005461:Fluorine; D005439:Flufenamic Acid; D010653:Phenylbutazone